Review and meta-analysis of epidemiologic studies of adult bipolar disorder

Journal of Clinical Psychiatry

Volumn 78, Issue 9, 2017, Pages e1259-e1269

  Moreira, Ana Lúcia R ^a,b   Van Meter, Anna ^c   Genzlinger, Jacquelynne ^d   Youngstrom, Eric A ^d  

^a Caldas da Rainha   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c YESHIVA UNIVERSITY   (United States)

^d The University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; AGE DISTRIBUTION; ASIA; BIPOLAR DISORDER; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HUMAN; MANIA; NORTH AMERICA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SOUTH AMERICA; STRUCTURED INTERVIEW; ADULT; META ANALYSIS;

ADULT; BIPOLAR DISORDER; HUMANS; PREVALENCE;

EID: 85040080699     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.16r11165     Document Type: Review

References (121)

1. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization; 2008.
2. Pompili M, Gonda X, Serafini G, et al. Epidemiology of suicide in bipolar disorders: a systematic review of the literature. Bipolar Disord. 2013;15(5):457–490.
3. Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey initiative. Arch Gen Psychiatry. 2011;68(3):241–251.
4. Buhagiar K, Parsonage L, Osborn DP. Physical health behaviours and health locus of control in people with schizophrenia-spectrum disorder and bipolar disorder: a cross-sectional comparative study with people with non-psychotic mental illness. BMCPsychiatry. 2011;11(1):104.
5. De Hert M, Cohen D, Bobes J, et al. Physical illness in patients with severe mental disorders, II: barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. WorldPsychiatry. 2011;10(2):138–151.
6. Pini S, de Queiroz V, Pagnin D, et al. Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol. 2005;15(4):425–434.
7. Hirschfeld RM, Vornik LA. Bipolar disorder—costs and comorbidity. AmJManagCare. 2005;11(suppl):S85–S90.
8. Kleinman L, Lowin A, Flood E, et al. Costs of bipolar disorder. Pharmacoeconomics. 2003;21(9):601–622.
9. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. ArchGenPsychiatry. 2007;64(5):543–552.
10. Petryshen TL, Sabeti PC, Aldinger KA, et al. Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Mol Psychiatry. 2010;15(8):810–815.
11. Chen C, et al. Population migration and the variation of dopamine D4 receptor (DRD4) allele frequencies around the globe. EvolHum Behav. 1999;20(5):309–324.
12. Hibbeln JR. Fish consumption and major depression. Lancet. 1998;351(9110):1213.
13. Kapusta ND, Mossaheb N, Etzersdorfer E, et al. Lithium in drinking water and suicide mortality. BrJPsychiatry. 2011;198(5):346–350.
14. Moreno C, Laje G, Blanco C, et al. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry. 2007;64(9):1032–1039.
15. Post RM, Leverich GS, Altshuler LL, et al. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany. IntClinPsychopharmacol. 2011;26(2):96–106.
16. Gershon ES, Hamovit JH, Guroff JJ, et al. Birth-cohort changes in manic and depressive disorders in relatives of bipolar and schizoaffective patients. ArchGenPsychiatry. 1987;44(4):314–319.
17. Parry P, Allison S. Pre-pubertal paediatric bipolar disorder: a controversy from America. Australas Psychiatry. 2008;16(2):80–84.
18. Blader JC, Carlson GA. Increased rates of bipolar disorder diagnoses among US child, adolescent, and adult inpatients, 1996–2004. BiolPsychiatry. 2007;62(2):107–114.
19. Ghaemi SN, Sachs GS, Chiou AM, et al. Is bipolar disorder still underdiagnosed? are antidepressants overutilized? J Affect Disord. 1999;52(1–3):135–144.
20. Zimmerman M, Ruggero CJ, Chelminski I, et al. Is bipolar disorder overdiagnosed? JClin Psychiatry. 2008;69(6):935–940.
21. Cerimele JM, Chwastiak LA, Dodson S, et al. The prevalence of bipolar disorder in general primary care samples: a systematic review. Gen Hosp Psychiatry. 2014;36(1):19–25.
22. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291(21):2581–2590.
23. Jenkins MM, Youngstrom EA, Washburn JJ, et al. Evidence-based strategies improve assessment of pediatric bipolar disorder by community practitioners. ProfPsycholResPr. 2011;42(2):121–129.
24. Mackin P, Targum SD, Kalali A, et al. Culture and assessment of manic symptoms. BrJPsychiatry. 2006;189(4):379–380.
25. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. JAffect Disord. 2003;73(1–2):123–131.
26. Van Meter AR, Moreira AL, Youngstrom EA. Meta-analysis of epidemiologic studies of pediatric bipolar disorder. JClinPsychiatry. 2011;72(9):1250–1256.
27. Regeer EJ, ten Have M, Rosso ML, et al. Prevalence of bipolar disorder in the general population: a reappraisal study of the Netherlands Mental Health Survey and Incidence Study. Acta Psychiatr Scand. 2004;110(5):374–382.
28. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264(19):2511–2518.
29. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276(4):293–299.
30. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. ArchGenPsychiatry. 1994;51(1):8–19.
31. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IVdisorders in the National Comorbidity Survey Replication. ArchGenPsychiatry. 2005;62(6):593–602.
32. Rin H, Lin TY. Mental illness among Formosan aborigines as compared with the Chinese in Taiwan. JMentSci. 1962;108:134–146.
33. Gureje O, Lasebikan VO, Kola L, et al. Lifetime and 12-month prevalence of mental disorders in the Nigerian Survey of Mental Health and Well-Being. BrJPsychiatry. 2006;188(5):465–471.
34. Orley J, Wing JK. Psychiatric disorders in two African villages. ArchGenPsychiatry. 1979;36(5):513–520.
35. American Psychiatric Association; Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders. Second Edition. Washington, DC: American Psychiatric Association; 1968.
36. Baldessarini RJ. A plea for integrity of the bipolar disorder concept. Bipolar Disord. 2000;2(1):3–7.
37. Clemente AS, Diniz BS, Nicolato R, et al. Bipolar disorder prevalence: a systematic review and meta-analysis of the literature. Rev Bras Psiquiatr. 2015;37(2):155–161.
38. Rettew DC, Lynch AD, Achenbach TM, et al. Meta-analyses of agreement between diagnoses made from clinical evaluations and standardized diagnostic interviews. IntJ MethodsPsychiatrRes. 2009;18(3):169–184.
39. Faravelli C, Abrardi L, Bartolozzi D, et al. The Sesto Fiorentino study: background, methods and preliminary results: lifetime prevalence of psychiatric disorders in an Italian community sample using clinical interviewers. Psychother Psychosom. 2004;73(4):216–225.
40. Kessler RC, Merikangas KR, Wang PS. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol. 2007;3(1):137–158.
41. Steiner JL, Tebes JK, Sledge WH, et al. A comparison of the Structured Clinical Interview for DSM-III-R and clinical diagnoses. J Nerv Ment Dis. 1995;183(6):365–369.
42. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. JClinEpidemiol. 2008;61(4):344–349.
43. Lipsey MW, Wilson DB. PracticalMeta-Analysis. Thousand Oaks, CA: Sage Publications; 2001.
44. Viechtbauer W. Conducting meta-analyses in R with the metafor package. JStatSoftw. 2010;36(3):1–48.
45. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950;21(4):607–611.
46. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193–206.
47. Aalto-Setala T, Marttunen M, Tuulio-Henriksson A, et al. One-month prevalence of depression and other DSM-IV disorders among young adults. Psychol Med. 2001;31(5):791–801.
48. Abou-Saleh MT, Ghubash R, Daradkeh TK. A1 Ain Community Psychiatric Survey, I: prevalence and socio-demographic correlates. Soc Psychiatry Psychiatr Epidemiol. 2001;36(1):20–28.
49. Alhasnawi S, Sadik S, Rasheed M, et al. The prevalence and correlates of DSM-IV disorders in the Iraq Mental Health Survey (IMHS). World psychiatry. 2009;8(2):97-109.
50. Almeida-Filho N, Mari Jde J, Coutinho E, et al. Brazilian multicentric study of psychiatric morbidity: methodological features and prevalence estimates. BrJPsychiatry. 1997;171(6):524–529.
51. Angst J, Gamma A, Neuenschwander M, et al. Prevalence of mental disorders in the Zurich Cohort Study: a twenty year prospective study. EpidemiolPsichiatrSoc. 2005;14(2):68–76.
52. Ansseau M, Dierick M, Buntinkx F, et al. High prevalence of mental disorders in primary care. J Affect Disord. 2004;78(1):49–55.
53. Baruffol E, Thilmany MC. Anxiety, depression, somatization and alcohol abuse: prevalence rates in a general Belgian community sample. Acta Psychiatr Belg. 1993;93(3):136–153.
54. Beesdo K, Hofler M, Leibenluft E, et al. Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life. Bipolar Disord. 2009;11(6):637–649.
55. Calvo-Perxas L, Garre-Olmo J, Vilalta-Franch J. Prevalence and sociodemographic correlates of depressive and bipolar disorders in Catalonia (Spain) using DSM-5criteria. JAffect Disord. 2015;184:97–103.
56. Canino GJ, Bird HR, Shrout PE, et al. The prevalence of specific psychiatric disorders in Puerto Rico. ArchGenPsychiatry. 1987;44(8):727–735.
57. Chen CN, Wong J, Lee N, et al. The Shatin community mental health survey in Hong Kong, II: major findings. ArchGenPsychiatry. 1993;50(2):125–133.
58. Faravelli C, Rosi S, Alessandra, et al. Threshold and subthreshold bipolar disorders in the Sesto Fiorentino Study. J Affect Disord. 2006;94(1–3):111–119.
59. Fassassi S, Vandeleur C, Aubry JM, et al. Prevalence and correlates of DSM-5 bipolar and related disorders and hyperthymic personality in the community. J Affect Disord. 2014;167:198–205.
60. Fekadu A, Shibre T, Alem A, et al. Bipolar disorder among an isolated island community in Ethiopia. J Affect Disord. 2004;80(1):1–10.
61. Fogarty F, Russell JM, Newman SC, et al. Epidemiology of psychiatric disorders in Edmonton: mania. ActaPsychiatrScandsuppl. 1994;376(s376):16–23.
62. Fones CS, Kua EH, Ng TP, Ko SM. Studying the mental health of a nation: a preliminary report on a population survey in Singapore. SingaporeMedJ. 1998;39(6):251–255.
63. Ford BC, Bullard KM, Taylor RJ, et al. Lifetime and 12-month prevalence of Diagnosticand StatisticalManualofMentalDisorders, Fourth Edition disorders among older African Americans: findings from the National Survey of American Life. AmJGeriatrPsychiatry. 2007;15(8):652–659.
64. Ghanem M, Gadallah M, Meky FA, Mourad S, El-Kholy G. National Survey of Prevalence of Mental Disorders in Egypt: preliminary survey. EMediterrHealthJ. 2009;15(1):65–75.
65. Ghubash R, Hamdi E, Bebbington P. The Dubai Community Psychiatric Survey: I, prevalence and socio-demographic correlates. Soc Psychiatry Psychiatr Epidemiol. 1992;27(2):53–61.
66. Grant BF, Stinson FS, Hasin DS, et al. Prevalence, correlates, and comorbidity of bipolar I disorder and Axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JClinPsychiatry. 2005;66(10):1205–1215.
67. Hsu JH, Chien IC, Lin CH. Increased risk of hyperlipidemia in patients with bipolar disorder: a population-based study. Gen Hosp Psychiatry. 2015;37(4):294–298.
68. Hwu HG, Yeh EK, Chang LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr Scand. 1989;79(2):136–147.
69. Jacobi F, Wittchen HU, Holting C, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). PsycholMed. 2004;34(4):597–611.
70. Jaju S, Al-Adawi S, Al-Kharusi H, et al. Prevalence and age-of-onset distributions of DSM-IVmental disorders and their severity among school going Omani adolescents and youths: WMH-CIDI findings. ChildAdolesc PsychiatryMentHealth. 2009;3(1):29.
71. Jansen K, Ores, Lda C, et al. Prevalence of episodes of mania and hypomania and associated comorbidities among young adults. J Affect Disord. 2011;130(1–2):328–333.
72. Jonas BS, Brody D, Roper M, et al. Prevalence of mood disorders in a national sample of young American adults. Soc Psychiatry Psychiatr Epidemiol. 2003;38(11):618–624.
73. Karam EG, Mneimneh ZN, Dimassi H, et al. Lifetime prevalence of mental disorders in Lebanon: first onset, treatment, and exposure to war. PLoSMed. 2008;5(4):e61.
74. Kawakami N, Shimizu H, Haratani T, et al. Lifetime and 6-month prevalence of DSM-III-R psychiatric disorders in an urban community in Japan. Psychiatry Res. 2004;121(3):293–301.
75. Kennedy N, Boydell J, Kalidindi S, et al. Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry. 2005;162(2):257–262.
76. Keqing L, Ze C, Lijun C, et al. Epidemiological survey of mental disorders in the people aged 18 and older in Hebei Province. Asian J Ps chiatr 2008;1(2):51–55
77. Kim-Cohen J, Caspi A, Moffitt TE, et al. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. ArchGen Psychiatry. 2003;60(7):709–717.
78. Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study. AmJPsychiatry. 2001;158(7):1091–1098.
79. Kringlen E, Torgersen S, Cramer V. Mental illness in a rural area: a Norwegian psychiatric epidemiological study. Soc Psychiatry Psychiatr Epidemiol. 2006;41(9):713–719.
80. Lee CK, Kwak YS, Yamamoto J, et al. Psychiatric epidemiology in Korea, part I: gender and age differences in Seoul. JNervMentDis. 1990;178(4):242–246.
81. Levav I, Kohn R, Dohrenwend BP, et al. An epidemiological study of mental disorders in a 10-year cohort of young adults in Israel. PsycholMed. 1993;23(3):691–707.
82. Levinson D, Zilber N, Lerner Y, Grinshpoon A, Levav I. Prevalence of mood and anxiety disorders in the community: results from the Israel National Health Survey. IsrJPsychiatry RelatSci. 2007;44(2):94–103.
83. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord. 2000;2(3 pt 2):281–293.
84. McConnell P, Bebbington P, McClelland R, et al. Prevalence of psychiatric disorder and the need for psychiatric care in Northern Ireland: population study in the District of Derry. Br J Psychiatry. 2002;181(3):214–219.
85. McDonald KC, Bulloch AG, Duffy A, et al. Prevalence of bipolar I and II disorder in Canada. CanJPsychiatry. 2015;60(3):151–156.
86. Medina-Mora ME, Borges G, Lara C, et al. Prevalence, service use, and demographic correlates of 12-month DSM-IVpsychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey. PsycholMed. 2005;35(12):1773–1783.
87. Mitchell PB, Slade T, Andrews G. Twelvemonth prevalence and disability of DSM-IV bipolar disorder in an Australian general population survey. PsycholMed. 2004;34(5):777–785.
88. Mohammadi MR, Davidian H, Noorbala AA, et al. An epidemiological survey of psychiatric disorders in Iran. ClinPractEpidemolMent Health. 2005;1(1):16.
89. Moreno DH, Andrade LH. The lifetime prevalence, health services utilization and risk of suicide of bipolar spectrum subjects, including subthreshold categories in the Sao Paulo ECA study. J Affect Disord. 2005;87(2–3):231–241.
90. Negash A, Alem A, Kebede D, et al. Prevalence and clinical characteristics of bipolar I disorder in Butajira, Ethiopia: a community-based study. J Affect Disord. 2005;87(2-3):193–201.
91. Oakley Browne MA, Wells JE, Scott KM, et al. Lifetime prevalence and projected lifetime risk of DSM-IV disorders in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust N Z J Psychiatry. 2006;40(10):865–874.
92. Paaren A, von Knorring AL, Olsson G, et al. Hypomania spectrum disorders from adolescence to adulthood: a 15-year followup of a community sample. J Affect Disord. 2013;145(2):190–199.
93. Pakriev S, Vasar V, Aluoja A, et al. Prevalence of mood disorders in the rural population of Udmurtia. Acta Psychiatr Scand. 1998;97(3):169–174.
94. Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet. 2009;373(9680):2041–2053.
95. Pratt LA. Characteristics of adults with serious mental illness in the United States household population in 2007. Psychiatr Serv. 2012;63(10):1042–1046.
96. Preville M, Boyer R, Grenier S, et al. The epidemiology of psychiatric disorders in Quebec’s older adult population. Can J Psychiatry. 2008;53(12):822–832.
97. Ritchie K, Artero S, Beluche I, et al. Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry. 2004;184(2):147–152.
98. Santos DN, Almeida-Filho N, Cruz SS, et al. Mental disorders prevalence among female caregivers of children in a cohort study in Salvador, Brazil. Rev Bras Psiquiatr. 2006;28(2):111–117.
99. Sareen J, Stein MB, Campbell DW, et al. The relation between perceived need for mental health treatment, DSM diagnosis, and quality of life: a Canadian population-based survey. Can J Psychiatry. 2005;50(2):87–94.
100. Schaffer A, Cairney J, Cheung A, et al. Community survey of bipolar disorder in Canada: lifetime prevalence and illness characteristics. CanJPsychiatry. 2006;51(1):9–16.
101. Scully PJ, Owens JM, Kinsella A, et al. Schizophrenia, schizoaffective and bipolar disorder within an epidemiologically complete, homogeneous population in rural Ireland: small area variation in rate. Schizophr Res. 2004;67(2–3):143–155.
102. Shen YC, Zhang MY, Huang YQ, et al. Twelvemonth prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. PsycholMed. 2006;36(2):257–267.
103. Slade T, Johnston A, Oakley Browne MA, et al. 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust N Z J Psychiatry. 2009;43(7):594–605.
104. Smith DJ, Nicholl BI, Cullen B, et al. Prevalence and characteristics of probable major depression and bipolar disorder within UK Biobank: cross-sectional study of 172,751 participants. PLoSOne. 2013;8(11):e75362.
105. Song J, Bergen SE, Kuja-Halkola R, et al. Bipolar disorder and its relation to major psychiatric disorders: a family-based study in the Swedish population. Bipolar Disord. 2015;17(2):184–193.
106. Stefánsson JG, Lindal E, Bjornsson JK, et al. Lifetime prevalence of specific mental disorders among people born in Iceland in 1931. Acta Psychiatr Scand. 1991;84(2):142–149.
107. Subramaniam M, Abdin E, Vaingankar JA, et al. Prevalence, correlates, comorbidity and severity of bipolar disorder: results from the Singapore Mental Health Study. JAffect Disord. 2013;146(2):189–196.
108. Suvisaari J, Aalto-Setälä T, Tuulio-Henriksson A, et al. Mental disorders in young adulthood. PsycholMed. 2009;39(2):287–299.
109. Szádóczky E, Papp Zs, Vitrai J, et al. The prevalence of major depressive and bipolar disorders in Hungary: results from a national epidemiologic survey. J Affect Disord. 1998;50(2–3):153–162.
110. ten Have M, Vollebergh W, Bijl R, et al. Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord. 2002;68(2–3):203–213.
111. Vazquez-Barquero JL, Diez-Manrique JF, Pena C, et al. Two stage design in a community survey. BrJPsychiatry. 1986;149(1):88–97.
112. Vega WA, Kolody B, Aguilar-Gaxiola S, et al. Lifetime prevalence of DSM-III-R psychiatric disorders among urban and rural Mexican Americans in California. Arch Gen Psychiatry. 1998;55(9):771–778.
113. Vicente B, Kohn R, Rioseco P, et al. Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study. AmJPsychiatry. 2006;163(8):1362–1370.
114. Wells JE, Bushnell JA, Hornblow AR, et al. Christchurch Psychiatric Epidemiology Study, part I: methodology and lifetime prevalence for specific psychiatric disorders. AustNZJ Psychiatry. 1989;23(3):315–326.
115. Yamamoto J, Silva JA, Sasao T, et al. Alcoholism in Peru. AmJPsychiatry. 1993;150(7):1059–1062.
116. Zutshi A, Eckert KA, Hawthorne G, et al. Changes in the prevalence of bipolar disorders between 1998 and 2008 in an Australian population. Bipolar Disord. 2011;13(2):182–188.
117. Ishikawa H, Kawakami N, Kessler RC. Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: results from the final dataset of World Mental Health Japan Survey. EpidemiolPsychiatrSci. 2016;25(3):217–229.
118. Akiskal HS, Bourgeois ML, Angst J, et al. Reevaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. 2000;59(suppl 1):S5–S30.
119. Van Meter AR, Youngstrom EA. Cyclothymic disorder in youth: why is it overlooked, what do we know and where is the field headed? Neuropsychiatry. 2012;2(6):509–519.
120. Streiner D, Norman GR, Cairney J. Health Measurement Scales: A Practical Guide to Their Development and Use. 5th ed. Geneva, Switzerland: Oxford University Press; 2015.
121. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva, Switzerland: World Health Organization; 2009.